Clinical Trial Update: Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation? [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating extended (6-week) preloading of varenicline to facilitate smoking reduction and cessation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking Cessation

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED